galantamine has been researched along with atropine in 32 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (40.63) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 11 (34.38) | 29.6817 |
| 2010's | 7 (21.88) | 24.3611 |
| 2020's | 1 (3.13) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Curtis, MA; Lin, SX; Sperry, J | 1 |
| Kozarev, I; Tashev, T | 1 |
| Vinogradova, VM | 1 |
| Schmidt, J; Wolf, H | 1 |
| Baraka, A; Cozanitis, DA; Karhunen, P; Nuuttila, K | 1 |
| Il'iuchenok, RIu; Vol'f, NV | 1 |
| Cozanitis, DA; Toivakka, E | 1 |
| Ilyutchenok, RY; Zinevich, VS | 1 |
| Gumulka, W; Kostowski, W | 1 |
| Irmis, F; Klingberg, F; Pickenhain, L | 1 |
| Wislicki, L | 1 |
| Fedorov, VI | 1 |
| STOYANOV, E; VULCHANOVA, S | 1 |
| STOJANOV, EA | 1 |
| Getova, DP; Krustev, AD; Sirakov, VN; Turiiski, VI | 1 |
| Bermudez, I; Groot-Kormelink, PJ; Smulders, CJ; van Kleef, RG; Vijverberg, HP; Zwart, R | 1 |
| Disterhoft, JF; Oh, MM; Power, JM; Wu, WW | 1 |
| Badia, A; Camps, P; Clos, MV; Muñoz-Torrero, D; Roman, S | 1 |
| Adler, M; Albuquerque, EX; Aracava, Y; Fawcett, WP; Hamilton, TA; Kan, RK; Oliveira, M; Pereira, EF; Randall, WR; Romano, JA | 1 |
| Kellar, KJ | 1 |
| Albuquerque, EX; Lopes, C; Njar, V; Pereira, EF; Purushottamachar, P; Schwarcz, R; Wu, HQ | 1 |
| Clark, MG; Finneran, K; Hilmas, CJ; Poole, MJ; Williams, PT | 1 |
| Akkerman, M; Albuquerque, EX; Alkondon, M; Aracava, Y; Merchenthaler, I; Pereira, EF | 1 |
| Nezhinskaya, GI; Sapronov, NS; Vladykin, AL | 1 |
| Acharya, J; Dubey, DK; Golime, R; Palit, M | 1 |
2 review(s) available for galantamine and atropine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Pyridine alkaloids with activity in the central nervous system.
Topics: Alkaloids; Amphibians; Animals; Bacteria; Central Nervous System Diseases; Fungi; Nicotine; Plants; Pyridines; Receptors, Nicotinic | 2020 |
2 trial(s) available for galantamine and atropine
| Article | Year |
|---|---|
Changes in cardiac rhythm with galanthamine hydrobromide.
Topics: Adolescent; Adult; Aged; Arrhythmias, Cardiac; Atropine; Blood Pressure; Carbon Dioxide; Drug Combinations; Electrocardiography; Female; Galantamine; Heart; Heart Rate; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Oxygen | 1973 |
A comparative study of galanthamine hydrobromide and atropine-neostigmine in conscious volunteers.
Topics: Adult; Atropine; Blood Glucose; Blood Pressure; Cholinesterase Inhibitors; Electroencephalography; Eosinophils; Female; Galantamine; Heart Rate; Humans; Leukocyte Count; Neostigmine; Time Factors | 1971 |
28 other study(ies) available for galantamine and atropine
| Article | Year |
|---|---|
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
[Experimental and clinical research on the antidote properties of nivalin in acute atropine poisoning].
Topics: Acute Disease; Adolescent; Adult; Animals; Antidotes; Atropine; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Evaluation; Drug Evaluation, Preclinical; Female; Galantamine; Guinea Pigs; Humans; Lethal Dose 50; Male | 1985 |
[The role of cholinergic processes in the synaptic transmission in the brain cortex].
Topics: Action Potentials; Animals; Atropine; Cerebral Cortex; Galantamine; Parasympatholytics; Parasympathomimetics; Rabbits; Synapses; Synaptic Transmission | 1967 |
[Influence of atropine and cholinesterase inhibitors on brain potentials caused by dental pulp stimulation].
Topics: Animals; Atropine; Brain; Cholinesterase Inhibitors; Dental Pulp; Electric Stimulation; Evoked Potentials; Female; Galantamine; Isoflurophate; Male; Paraoxon; Physostigmine; Rabbits | 1972 |
[Effect of amizil and atropine on hippocampal-amygdaloid evoked potentials].
Topics: Amygdala; Animals; Atropine; Benactyzine; Cats; Electric Stimulation; Evoked Potentials; Galantamine; Hippocampus | 1972 |
Short latency reticulocortical potentials: effect of muscarinic anticholinergic drugs.
Topics: Action Potentials; Animals; Atropine; Benactyzine; Cats; Cholinesterase Inhibitors; Dendrites; Electric Stimulation; Galantamine; Mesencephalon; Parasympatholytics; Parasympathomimetics; Peripheral Nerves; Reticular Formation; Synapses | 1970 |
Note on the ganglionic and central actions of galantamine.
Topics: Acetylcholine; Animals; Atropine; Benactyzine; Cats; Cerebral Cortex; Electroencephalography; Evoked Potentials; Galantamine; Ganglia, Autonomic; Hexamethonium Compounds; Hippocampus; Phenobarbital; Physostigmine; Stimulation, Chemical; Tubocurarine | 1968 |
[The effect of prothiadene and atropine on nivaline induced electrobiological and behavioral changes].
Topics: Animals; Atropine; Behavior, Animal; Electrophysiology; Galantamine; Higher Nervous Activity; Hippocampus; Rats; Tranquilizing Agents | 1967 |
Nivalin (galanthamine hydrobromide), an additional decurarizing agent. Some introductory observations.
Topics: Adolescent; Adult; Anticholesteremic Agents; Atropine; Blood Pressure; Female; Galantamine; Heart Rate; Humans; Male; Middle Aged; Muscles; Neostigmine; Salivation | 1967 |
[Effect of parasympathetic agents on renin secretion in vitro].
Topics: Animals; Atropine; Diphenylacetic Acids; Galantamine; Ganglionic Blockers; Hexamethonium Compounds; In Vitro Techniques; Kidney Cortex; Neostigmine; Parasympatholytics; Parasympathomimetics; Pilocarpine; Pyrrolizidine Alkaloids; Quaternary Ammonium Compounds; Quinuclidines; Rats; Renin | 1984 |
THE CLINICAL APPLICATION OF NIVALIN AS AN ANTIDOTE OF CURARE.
Topics: Adjuvants, Anesthesia; Antidotes; Atropine; Curare; Galantamine; Humans; Neuromuscular Nondepolarizing Agents; Postoperative Care; Toxicology | 1963 |
[GALANTHAMINUM HYDROBROMICUM ("NIVALINE"), A NEW ANTIDOTE OF NON-POLARIZING MUSCLE RELAXANTS. PHARMACOLOGY AND CLINICAL USE].
Topics: Anesthesia; Anesthesiology; Animals; Antidotes; Atropine; Biomedical Research; Bradycardia; Cats; Galantamine; Mice; Muscle Relaxants, Central; Neostigmine; Neuromuscular Nondepolarizing Agents; Pharmacology; Rabbits; Rats | 1964 |
In vivo and in vitro study of the influence of the anticholinesterase drug galantamine on motor and evacuative functions of rat gastrointestinal tract.
Topics: Animals; Atropine; Cholinergic Antagonists; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Duodenum; Galantamine; Gastrointestinal Motility; Gastrointestinal Tract; Ileum; In Vitro Techniques; Ipratropium; Jejunum; Male; Methysergide; Muscle Contraction; Muscle, Smooth; Peristalsis; Radiography; Rats; Rats, Wistar; Stomach | 2004 |
Cholinergic drugs potentiate human nicotinic alpha4beta2 acetylcholine receptors by a competitive mechanism.
Topics: Acetylcholine; Alkaloids; Animals; Atropine; Azocines; Binding, Competitive; Cholinergic Agents; Cholinesterase Inhibitors; Dichlorvos; Dose-Response Relationship, Drug; Female; Galantamine; Humans; Membrane Potentials; Models, Biological; Nicotine; Oocytes; Phenylcarbamates; Physostigmine; Plasmids; Quinolizines; Receptors, Nicotinic; Rivastigmine; Scopolamine; Tacrine; Xenopus laevis | 2005 |
Galantamine increases excitability of CA1 hippocampal pyramidal neurons.
Topics: Action Potentials; Aging; Animals; Atropine; Bungarotoxins; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Excitatory Postsynaptic Potentials; Female; Galantamine; Hippocampus; Muscarinic Antagonists; Nicotinic Antagonists; Organ Culture Techniques; Patch-Clamp Techniques; Pyramidal Cells; Rabbits; Receptors, Muscarinic; Receptors, Nicotinic; Synaptic Transmission | 2006 |
Nicotinic-receptor potentiator drugs, huprine X and galantamine, increase ACh release by blocking AChE activity but not acting on nicotinic receptors.
Topics: Acetylcholine; Alkaloids; Aminoquinolines; Animals; Atropine; Cholinesterase Inhibitors; Dopamine Antagonists; Dose-Response Relationship, Drug; Galantamine; Haloperidol; Heterocyclic Compounds, 4 or More Rings; In Vitro Techniques; Mecamylamine; Nicotinic Agonists; Nicotinic Antagonists; Parasympatholytics; Perfusion; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Sesquiterpenes | 2005 |
Effective countermeasure against poisoning by organophosphorus insecticides and nerve agents.
Topics: Acetylcholinesterase; Alkaloids; Animals; Atropine; Behavior, Animal; Brain; Chemical Warfare Agents; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Drug Therapy, Combination; Galantamine; Guinea Pigs; Insecticides; Lethal Dose 50; Neurons; Organophosphate Poisoning; Organophosphorus Compounds; Paraoxon; Poisoning; Pyridostigmine Bromide; Sarin; Sesquiterpenes; Soman; Time Factors | 2006 |
Overcoming inhibitions.
Topics: Acetylcholine; Acetylcholinesterase; Animals; Atropine; Benzodiazepines; Blood-Brain Barrier; Brain; Chemical Warfare Agents; Cholinesterase Inhibitors; Drug Therapy, Combination; Galantamine; Guinea Pigs; Insecticides; Neurons; Neurotransmitter Agents; Organophosphate Poisoning; Organophosphates; Organophosphorus Compounds; Paraoxon; Pralidoxime Compounds; Pyridostigmine Bromide; Receptors, Cholinergic; Receptors, Muscarinic; Sarin; Seizures; Soman; Time Factors | 2006 |
Competitive antagonism between the nicotinic allosteric potentiating ligand galantamine and kynurenic acid at alpha7* nicotinic receptors.
Topics: Allosteric Regulation; alpha7 Nicotinic Acetylcholine Receptor; Alzheimer Disease; Animals; Atropine; Cells, Cultured; Choline; Corpus Striatum; Dopamine; Galantamine; Kynurenic Acid; Male; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic | 2007 |
Galantamine is a novel post-exposure therapeutic against lethal VX challenge.
Topics: Acetylcholinesterase; Animals; Antidotes; Atropine; Cholinesterase Inhibitors; Cholinesterase Reactivators; Diaphragm; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electroencephalography; Erythrocytes; Galantamine; Guinea Pigs; Male; Muscle Fatigue; Muscle Tonus; Neurotoxicity Syndromes; Organothiophosphorus Compounds; Paralysis; Phrenic Nerve; Pralidoxime Compounds; Seizures; Time Factors | 2009 |
Molecular and cellular actions of galantamine: clinical implications for treatment of organophosphorus poisoning.
Topics: Acetylcholinesterase; Animals; Atropine; Brain; Chemical Warfare Agents; Cholinergic Fibers; Cholinesterase Inhibitors; Cholinesterase Reactivators; Drug Interactions; Female; Galantamine; Guinea Pigs; Lethal Dose 50; Male; Muscarinic Antagonists; Nerve Degeneration; Organ Culture Techniques; Organophosphate Poisoning; Organophosphorus Compounds; Sarin; Soman; Treatment Outcome | 2010 |
Effects of cholinergic agonists and antagonists under conditions of spleen denervation in rats with endotoxic shock.
Topics: Animals; Atropine; Cholinergic Agonists; Denervation; Galantamine; Glycerylphosphorylcholine; Heart Rate; Ipratropium; Lipopolysaccharides; Male; Muscarinic Antagonists; Nicotinic Agonists; Rats; Rats, Wistar; Salmonella typhi; Serotonin; Shock, Septic; Spleen | 2010 |
Neuroprotective Effects of Galantamine on Nerve Agent-Induced Neuroglial and Biochemical Changes.
Topics: Acetylcholinesterase; Animals; Atropine; Brain; Brain-Derived Neurotrophic Factor; Galantamine; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Male; Muscarinic Antagonists; Nerve Agents; Neuroglia; Neuroprotective Agents; Protein Carbonylation; Proto-Oncogene Proteins c-fos; Rats; Rats, Wistar; RNA, Messenger; S100 Calcium Binding Protein beta Subunit; Soman; Time Factors | 2018 |